Trilogy Capital Inc. Bristol Myers Squibb CO Transaction History
Trilogy Capital Inc.
- $1.7 Billion
- Q1 2024
A detailed history of Trilogy Capital Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Trilogy Capital Inc. holds 60,484 shares of BMY stock, worth $2.42 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
60,484
Previous 52,806
14.54%
Holding current value
$2.42 Million
Previous $2.71 Million
21.08%
% of portfolio
0.19%
Previous 0.18%
Shares
13 transactions
Others Institutions Holding BMY
# of Institutions
2,553Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.45 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.51 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.67 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.56 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.81 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $85.2B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...